cy 208-243 has been researched along with Chemical Dependence in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Büscher, HH; Enz, A; Foote, RW; Gähwiler, BH; Maurer, R; Römer, D; Seiler, MP; Shearman, GT; Wüthrich, H | 1 |
1 other study(ies) available for cy 208-243 and Chemical Dependence
Article | Year |
---|---|
CY 208-243: a unique combination of atypical opioid antinociception and D1 dopaminomimetic properties.
Topics: Analgesics; Animals; Brain; Discrimination, Psychological; Drug Tolerance; Female; Hippocampus; In Vitro Techniques; Indoles; Macaca mulatta; Male; Mice; Mice, Inbred Strains; Morphine; Naloxone; Pain; Phenanthridines; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Opioid; Respiration; Substance-Related Disorders | 1988 |